Evidence map›Paper›PMID 40868409›Full record

ArticleBioengineering (Basel, Switzerland)2025

Introducing Holographic Surgical Navigation in Pediatric Wilms' Tumor Patients: A Feasibility Study During Total Nephrectomy.

Nick T de Groot, Jasper M van der Zee, Guus M J Bökkerink, Annemieke S Littooij, Caroline C C Hulsker, Cecilia E J Terwisscha van Scheltinga, Cornelis P van de Ven, Ruud C Wortel, Aart J Klijn, Marc H W A Wijnen and 2 more

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nick T de GrootDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Jasper M van der ZeeDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0001-9144-8852
Guus M J BökkerinkDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Annemieke S LittooijDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Caroline C C HulskerDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Cecilia E J Terwisscha van ScheltingaDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Cornelis P van de VenDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Ruud C WortelDepartment of Pediatric Urology, University Medical Center Utrecht/Wilhelmina Children's Hospital, 3584 EA Utrecht, The Netherlands.
Aart J KlijnDepartment of Pediatric Urology, University Medical Center Utrecht/Wilhelmina Children's Hospital, 3584 EA Utrecht, The Netherlands.
Marc H W A WijnenDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Matthijs FitskiDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0003-0515-7691
Alida F W van der SteegDepartment of Pediatric Oncology Surgery, Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0003-0168-7513

Funding

KWF Dutch Cancer Society 14714
6 · The paper itself

Abstract

Wilms' tumor is a common pediatric renal malignancy. In selected cases, nephron-sparing surgery (NSS) may be employed as part of the surgical approach. To prevent positive margins, optimal understanding of the tumor-kidney edge is essential. Augmented reality (AR) enables intraoperative visualization of patient-specific three-dimensional (3D) holograms. In this study, we aim to validate the clinical feasibility of a holographic landmark-based registration system in pediatric patients planned for a total nephrectomy (TN), to ensure that the holographic visualization will not influence surgical decision making. In a single-center prospective study, ten pediatric patients undergoing TN were included. Patient-specific 3D holograms were created from preoperative MRI, and intraoperatively landmark-based registration was performed using the HoloLens 2. Clinical feasibility was conducted using accuracy measurements, the System Usability Scale (SUS), and a self-developed questionnaire. Three out of ten patients had a successful registration with a median measured accuracy of 7.0 mm (Interquartile Range (IQR) 6-13.5) and a median SUS score of 75 (IQR 65-77.5). Surgeons reported improved depth perception and anatomical understanding. However, in seven out of ten patients, registration failed due to multiple reasons. The most important factors were large tumor volumes obstructing landmark placement and insufficient spatial distributions of the landmarks, causing rotational misalignment. Although AR showed potential in improving the depth perception and relation in anatomical structures, the landmark-based registration with the HoloLens 2 was currently deemed insufficient for clinical implementation in pediatric abdominal surgery.

Indexed as

augmented realityHoloLens 2landmark-based registrationnephron-sparing surgerytotal nephrectomyWilms’ tumor

Identifiers

PMID40868409
PMCPMC12383552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.